His research group specializes in the development of high-precision, scalable synthesis of nanomaterials and their applications, including nanomedicine.
He has taken part in more than one hundred research projects, in most of them as P.I., including three of the highly prestigious ERC Advanced Grants (HECTOR, 2011-16; CADENCE, 2017-23; and ROMEO, 2025-30) - the last two focused on developing catalysts and nanoparticles capable of fighting cancer, as well as novel methods to deliver them to the tumor.